角质形成细胞
炎症
化学
癌症研究
细胞生长
药理学
细胞培养
医学
伤口愈合
NFKB1型
皮肤老化
下调和上调
细胞生物学
信号转导
细胞凋亡
细胞因子
生物
作者
Yangang Zhang,Yufei Wu,Yuxiang Ren,Ziyan Yang,Jialin Lian,Li XiaoLi
摘要
Background:Psoriasis is a common immune-mediated chronic inflammatory skin disease.It is characterized by excessive proliferation of epidermal keratinocytes and persistent skin inflammation.Accumulating evidence indicates that aberrant arginine metabolism contributes to skin inflammatory disorders.SAT1 is a key rate-limiting enzyme in arginine and polyamine metabolic pathways.However, its expression pattern and biological function in psoriasis remain poorly understood. Material/Methods:Clinical skin specimens were collected from patients with psoriasis.SAT1 expression in lesional tissues was detected by immunofluorescence, qRT-PCR, and western blot.In vitro, HaCaT cells were stimulated with mixed pro-inflammatory cytokines, and SAT1 was silenced to evaluate its effect on CCND1 and KRT17 expression.In vivo, a psoriasis-like mouse model was induced by imiquimod (IMQ).Berenil, a pharmacological inhibitor of SAT1, was administered to assess its therapeutic effects on skin inflammation and epidermal hyperplasia. Results:In this preliminary pilot cohort, SAT1 showed a descriptive trend toward elevated expression in epidermal keratinocytes of psoriatic lesions at both mRNA and protein levels.In vitro, silencing SAT1 inhibited the cytokineinduced upregulation of CCND1 and KRT17 in HaCaT cells.In the IMQ-induced mouse model, Berenil treatment suggested a tendency to reduce ear erythema, swelling and epidermal hyperplasia.It also alleviated inflammatory cell infiltration and down-regulated Ccnd1 and Krt17 expression in skin tissues. Conclusions:Our findings suggest a potential role for SAT1 in promoting abnormal keratinocyte activation and hyperproliferation in this preliminary pilot cohort, which may contribute to psoriasis-like inflammatory lesions.Overall, this study provides preliminary evidence that links arginine metabolic reprogramming to psoriasis pathogenesis and suggests that SAT1 might be a candidate for further therapeutic exploration.
科研通智能强力驱动
Strongly Powered by AbleSci AI